Bio-Rad Laboratories (BIO) Other financing activities (2009 - 2016)

Bio-Rad Laboratories (BIO) has reported Other financing activities for 8 consecutive years, with $412000.0 the latest figure, recorded in Q4 2016.

• On a quarterly basis, Other financing activities rose 11.96% year-over-year to $412000.0 in Q4 2016; TTM through Sep 2017 was $412000.0, a 71.82% decrease from a year earlier, with the FY2025 full-year figure at $15.8 million, down 17.71% from the prior year.
• Other financing activities was $412000.0 for Q4 2016 at Bio-Rad Laboratories, down from $1.0 million in the prior quarter.
• Over five years, Other financing activities peaked at $2.0 million in Q3 2015 and troughed at $8000.0 in Q2 2016.
• A 5-year average of $603700.0 and a median of $354500.0 in 2012 frame the typical range for Other financing activities.
• Across the five-year window, Other financing activities surged 565.93% in 2015 and tumbled 94.47% in 2016, its largest moves.
• Over 5 years, Other financing activities stood at $2.0 million in 2012, then retreated by 2.65% to $1.9 million in 2013, then plunged by 69.51% to $583000.0 in 2014, then tumbled by 36.88% to $368000.0 in 2015, then advanced by 11.96% to $412000.0 in 2016.
• The last three Other financing activities figures came in at $412000.0 (Q4 2016), $1.0 million (Q3 2016), and $8000.0 (Q2 2016), per Business Quant data.